(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).It is indicated that the complaint device is not returning for evaluation; therefore, a failure analysis of the device could not be completed.The analysis of this complaint was an assessment of the information provided to abbott vascular, the manufacturing records, and complaint history.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined that the reported balloon rupture appears to be due to case circumstances.Based on the reviewed information, there is no indication the issue was caused by, or related to the design, manufacture, or labeling of the device.
|
It was reported that the procedure was to treat a 75% restenosed, heavily calcified shunt.The 8.0mmx40mmx80cm armada 35 balloon dilatation catheter (bdc) was unpackaged and prepped before use without issue.The bdc was advanced to the target lesion without issue; however, the balloon ruptured at 12 atmospheres (atm) and the bdc was removed without issue.There were no reported adverse patient effects and no reported clinically significant delay in the procedure.A new armada 35 bdc was used to successfully complete the procedure.There was no additional information provided.
|